These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32871789)

  • 21. A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT1.
    Enomoto K; Sato F; Tamagawa S; Gunduz M; Onoda N; Uchino S; Muragaki Y; Hotomi M
    Sci Rep; 2019 Oct; 9(1):14616. PubMed ID: 31601917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno-foetal amino acid transport.
    Zaugg J; Huang X; Ziegler F; Rubin M; Graff J; Müller J; Moser-Hässig R; Powell T; Gertsch J; Altmann KH; Albrecht C
    J Cell Mol Med; 2020 Nov; 24(21):12681-12693. PubMed ID: 33001560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics.
    Kanai Y
    Pharmacol Ther; 2022 Feb; 230():107964. PubMed ID: 34390745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JPH203, a selective L-type amino acid transporter 1 inhibitor, induces mitochondria-dependent apoptosis in Saos2 human osteosarcoma cells.
    Choi DW; Kim DK; Kanai Y; Wempe MF; Endou H; Kim JK
    Korean J Physiol Pharmacol; 2017 Nov; 21(6):599-607. PubMed ID: 29200902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism and pharmacokinetic studies of JPH203, an L-amino acid transporter 1 (LAT1) selective compound.
    Wempe MF; Rice PJ; Lightner JW; Jutabha P; Hayashi M; Anzai N; Wakui S; Kusuhara H; Sugiyama Y; Endou H
    Drug Metab Pharmacokinet; 2012; 27(1):155-61. PubMed ID: 21914964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemocompatible LAT1-inhibitor can induce apoptosis in cancer cells without affecting brain amino acid homeostasis.
    Markowicz-Piasecka M; Huttunen J; Montaser A; Huttunen KM
    Apoptosis; 2020 Jun; 25(5-6):426-440. PubMed ID: 32405891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of L-type amino acid transporter 1 is a poor prognostic factor for Non-Hodgkin's lymphoma.
    Jigjidkhorloo N; Kanekura K; Matsubayashi J; Akahane D; Fujita K; Oikawa K; Kurata A; Takanashi M; Endou H; Nagao T; Gotoh A; Norov O; Kuroda M
    Sci Rep; 2021 Nov; 11(1):21638. PubMed ID: 34737339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation.
    Cibrian D; Castillo-González R; Fernández-Gallego N; de la Fuente H; Jorge I; Saiz ML; Punzón C; Ramírez-Huesca M; Vicente-Manzanares M; Fresno M; Daudén E; Fraga-Fernandez J; Vazquez J; Aragonés J; Sánchez-Madrid F
    J Allergy Clin Immunol; 2020 Jan; 145(1):199-214.e11. PubMed ID: 31605740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells.
    Hayashi K; Jutabha P; Maeda S; Supak Y; Ouchi M; Endou H; Fujita T; Chida M; Anzai N
    J Pharmacol Sci; 2016 Nov; 132(3):201-204. PubMed ID: 27567475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into the Transport Cycle of LAT1 and Interaction with the Inhibitor JPH203.
    Brunocilla C; Console L; Rovella F; Indiveri C
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L-type Amino Acid Transporter 1 (SLC7A5)-Mediated Transport of Pregabalin at the Rat Blood-Spinal Cord Barrier and its Sensitivity to Plasma Branched-Chain Amino Acids.
    Akashi T; Noguchi S; Takahashi Y; Nishimura T; Tomi M
    J Pharm Sci; 2023 Apr; 112(4):1137-1144. PubMed ID: 36627052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.
    Takahashi Y; Nishimura T; Higuchi K; Noguchi S; Tega Y; Kurosawa T; Deguchi Y; Tomi M
    Pharm Res; 2018 Oct; 35(12):246. PubMed ID: 30374619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LAT1-specific inhibitor is effective against T cell-mediated allergic skin inflammation.
    Hayashi K; Kaminuma O; Nishimura T; Saeki M; Matsuoka K; Hiroi T; Jutabha P; Iwata Y; Sugiura K; Owada T; Kurasawa K; Okayasu I; Ouchi M; Fujita T; Kanai Y; Endou H; Anzai N
    Allergy; 2020 Feb; 75(2):463-467. PubMed ID: 31403710
    [No Abstract]   [Full Text] [Related]  

  • 34. The Anti-Tumor Effect of the Newly Developed LAT1 Inhibitor JPH203 in Colorectal Carcinoma, According to a Comprehensive Analysis.
    Otani R; Takigawa H; Yuge R; Shimizu D; Ariyoshi M; Miyamoto R; Kadota H; Hiyama Y; Hayashi R; Urabe Y; Ishikawa A; Oue N; Kitadai Y; Oka S; Tanaka S
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET).
    Habermeier A; Graf J; Sandhöfer BF; Boissel JP; Roesch F; Closs EI
    Amino Acids; 2015 Feb; 47(2):335-44. PubMed ID: 25385314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models.
    Shi Z; Kaneda-Nakashima K; Ohgaki R; Xu M; Okanishi H; Endou H; Nagamori S; Kanai Y
    Sci Rep; 2023 Aug; 13(1):13943. PubMed ID: 37626086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways.
    Zhao X; Sakamoto S; Maimaiti M; Anzai N; Ichikawa T
    Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells.
    Nishikubo K; Ohgaki R; Liu X; Okanishi H; Xu M; Endou H; Kanai Y
    Cancer Cell Int; 2023 Jun; 23(1):116. PubMed ID: 37322479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional activity of a large neutral amino acid transporter (LAT) in rabbit retina: a study involving the in vivo retinal uptake and vitreal pharmacokinetics of L-phenyl alanine.
    Atluri H; Talluri RS; Mitra AK
    Int J Pharm; 2008 Jan; 347(1-2):23-30. PubMed ID: 17686592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer.
    Shindo H; Harada-Shoji N; Ebata A; Sato M; Soga T; Miyashita M; Tada H; Kawai M; Kosaka S; Onuki K; Usami S; Furumoto S; Hayashi S; Abe T; Suzuki T; Ishida T; Sasano H
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.